[{"Assets_0_Q3_USD":120267000.0,"CommonStockSharesOutstanding_0_Q3_shares":19108221.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-15319000.0,"NetIncomeLoss_1_Q3_USD":-5663000.0,"NetIncomeLoss_3_Q3_USD":-17385000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":18955384.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":7319012.0,"StockholdersEquity_0_Q3_USD":114127000.0,"Ticker":"KZR","CIK":"1645666","name":"KEZAR LIFE SCIENCES, INC.","OfficialName":"Kezar Life Sciences Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"829139908.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]